Safety of Cardioversion of Acute Atrial Fibrillation "FinCV"
Completed
Phase N/A Results N/ASummary of Purpose
The purpose of this study is to investigate the complications of cardioversion of acute (<48 hours duration) atrial fibrillation (AF). Primary Outcome Measures: - Incidence and predictors of thromboembolic complications, especially stroke, and death <31 days after cardioversion of acute AF Secondary Outcome Measures: - Number of therapy non-responder and early recurrence of AF - ...
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 26 June 2012.
1 Jun 2011 | 16 Jun 2011 | 1 May 2012 | 1 Jun 2012 | 1 Jun 2012 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
- Observation: Cohort
- Perspective: Retrospective
- Sampling: Non-Probability Sample
Contacts
Not available
View Trial Locations
Recruitment
- Enrollment: 7,700
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 3 locations, 1 country
Principal Investigator
- Juhani Airaksinen, Professor
Turku University Hospital